Le Lézard
Classified in: Health, Covid-19 virus
Subject: CPG

COVID-19 Pandemic - Tabling of additional appropriations for 2020-2021


QUÉBEC CITY, Nov. 24, 2020 /CNW Telbec/ - The Minister Responsible for Government Administration and Chair of the Conseil du trésor, Sonia LeBel, today tabled additional appropriations totalling $10.1 billion, comprising $5.1 billion in sums to be voted and $5.0 billion in continuing appropriations. These additional sums are necessary to support Quebecers in the context of the current global pandemic and to enable the economic recovery. This tabling follows measures announced by the Minister of Finance in the Update on Québec's Economic and Financial Situation of this past November 12.

This increase in program spending, for the current year, includes an amount of $4.9 billion to reinforce our health system. These amounts will make it possible, among other things, to recognize the additional efforts of health care workers, to provide all the necessary protective equipment to deal with the crisis, and to implement other support measures.

Apart from the sums dedicated to Health and Social Services, the additional appropriations will also make it possible to fund the following measures:

Quote: 

"We have been on the job and in action since the beginning of the crisis, and our efforts will continue as long as the context demands, in order to protect and support our citizens and businesses ? and always with the firm intention of ensuring Québec's economic recovery. The additional appropriations tabled today are a reflection of our commitment to take all necessary means to minimize the impacts of the pandemic."

Sonia LeBel, Minister Responsible for Government Administration and Chair of the Conseil du trésor

Related link:

www.tresor.gouv.qc.ca 

SOURCE Cabinet de la ministre responsable de l'Administration gouvernementale et présidente du Conseil du trésor


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: